Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-01 4:37 pm Purchase | 2025-06-27 | 13G | Pyxis Oncology, Inc. PYXS | Millennium Management LLC | 3,542,663 5.700% | 3,542,663 (New Position) | Filing History |
| 2025-05-06 4:17 pm Sale | 2025-03-31 | 13G | Pyxis Oncology, Inc. PYXS | Integrated Core Strategies (US) LLC | 2,488,079 4.000% | -672,060 (-21.27%) | Filing History |
| 2025-04-02 9:25 pm Purchase | 2025-03-31 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 7,543,007 11.210% | 918,308 (+13.86%) | Filing History |
| 2025-02-14 4:01 pm Sale | 2024-12-31 | 13G | Pyxis Oncology, Inc. PYXS | Ridgeback Capital Investments L.P. | 359,231 0.600% | -3,985,997 (-91.73%) | Filing History |
| 2025-02-14 08:48 am Sale | 2024-12-31 | 13G | Pyxis Oncology, Inc. PYXS | Deep Track Capital, LP | 0 0.000% | -4,184,100 (Position Closed) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Pyxis Oncology, Inc. PYXS | BlackRock Inc. BLK | 3,344,141 5.600% | 3,344,141 (New Position) | Filing History |
| 2024-12-23 6:31 pm Purchase | 2024-12-23 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 6,624,699 10.300% | 1,135,000 (+20.68%) | Filing History |
| 2024-12-16 4:04 pm Purchase | 2024-12-09 | 13G | Pyxis Oncology, Inc. PYXS | Integrated Core Strategies (US) LLC | 3,160,139 5.300% | 3,160,139 (New Position) | Filing History |
| 2024-11-12 11:53 am Purchase | 2024-09-30 | 13G | Pyxis Oncology, Inc. PYXS | Laurion Capital Management LP | 3,625,974 6.150% | 455,171 (+14.36%) | Filing History |
| 2024-11-06 4:36 pm Unchanged | 2024-09-30 | 13G | Pyxis Oncology, Inc. PYXS | Bayer World Investments B.V. | 2,742,338 4.700% | 0 (Unchanged) | Filing History |
| 2024-04-03 5:10 pm Purchase | 2024-03-26 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 5,489,699 8.890% | 1,319,425 (+31.64%) | Filing History |
| 2024-03-08 4:03 pm Purchase | 2024-02-27 | 13G | Pyxis Oncology, Inc. PYXS | Deep Track Capital, LP | 4,184,100 7.870% | 4,184,100 (New Position) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | Pyxis Oncology, Inc. PYXS | TANG CAPITAL PARTNERS LP | 0 0.000% | -3,470,700 (Position Closed) | Filing History |
| 2024-02-14 09:28 am Sale | 2023-12-31 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,938,851 (Position Closed) | Filing History |
| 2024-01-26 4:36 pm Purchase | 2024-01-26 | 13G | Pyxis Oncology, Inc. PYXS | Ridgeback Capital Investments L.P. | 4,345,228 9.800% | 4,345,228 (New Position) | Filing History |
| 2023-04-04 4:58 pm Purchase | 2023-03-24 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 4,170,274 10.200% | 703,379 (+20.29%) | Filing History |
| 2023-03-23 4:20 pm Purchase | 2023-03-17 | 13G | Pyxis Oncology, Inc. PYXS | PFIZER INC PFE | 7,032,770 19.020% | 1,811,594 (+34.70%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RA Capital Management, L.P. | 0 0.000% | -2,282,173 (Position Closed) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | TANG CAPITAL PARTNERS LP | 3,470,700 9.900% | 1,489,274 (+75.16%) | Filing History |
| 2023-02-14 10:00 am Sale | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RTW Investments, LP | 0 0.000% | -2,120,760 (Position Closed) | Filing History |